In contrast, ZDHHC3 palmitates B7-H4, an immune checkpoint, at Cys130 in breast cancer cells, thus preventing it from being degraded by lysosomes and maintaining B7-H4-mediated tumour immunosuppression (6). Here, VTCN1 is linked to breast carcinoma.